Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20974610rdf:typepubmed:Citationlld:pubmed
pubmed-article:20974610lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0149931lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0150097lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0035527lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0677582lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0445202lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:20974610lifeskim:mentionsumls-concept:C0355642lld:lifeskim
pubmed-article:20974610pubmed:issue12lld:pubmed
pubmed-article:20974610pubmed:dateCreated2010-11-9lld:pubmed
pubmed-article:20974610pubmed:abstractTextRiboflavin seems to have a promising effect on migraine in adults. The present study examines whether riboflavin has a prophylactic effect on migraine in children.lld:pubmed
pubmed-article:20974610pubmed:languageenglld:pubmed
pubmed-article:20974610pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20974610pubmed:citationSubsetIMlld:pubmed
pubmed-article:20974610pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20974610pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20974610pubmed:statusMEDLINElld:pubmed
pubmed-article:20974610pubmed:monthDeclld:pubmed
pubmed-article:20974610pubmed:issn1468-2982lld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:PasschierJanJlld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:YingChuyanClld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:ArtsWillem-Fr...lld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:Duivenvoorden...lld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:LocherHeikoHlld:pubmed
pubmed-article:20974610pubmed:authorpubmed-author:BruijnJacques...lld:pubmed
pubmed-article:20974610pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20974610pubmed:volume30lld:pubmed
pubmed-article:20974610pubmed:ownerNLMlld:pubmed
pubmed-article:20974610pubmed:authorsCompleteYlld:pubmed
pubmed-article:20974610pubmed:pagination1426-34lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:meshHeadingpubmed-meshheading:20974610...lld:pubmed
pubmed-article:20974610pubmed:year2010lld:pubmed
pubmed-article:20974610pubmed:articleTitleMedium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.lld:pubmed
pubmed-article:20974610pubmed:affiliationVlietland Hospital, Schiedam, The Netherlands. jbruijn@ssvz.nllld:pubmed
pubmed-article:20974610pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20974610pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20974610pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed